A New Rapid-Acting Antidepressant
- PMID: 32243798
- DOI: 10.1016/j.cell.2020.02.033
A New Rapid-Acting Antidepressant
Abstract
The discovery of the strikingly rapid and robust antidepressant effects of r/s-ketamine for the treatment of antidepressant-resistant symptoms of depression has led to new insights into the biology of antidepressants and the FDA approval of its s-isomer, Esketamine (Spravato), the first mechanistically new treatment for depression in over 60 years. To view this Bench to Bedside, open or download the PDF.
Copyright © 2020. Published by Elsevier Inc.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
